Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 12, pp. 946-953
Open Access | Times Cited: 481

Showing 1-25 of 481 citing articles:

Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta, Jeffrey W. Pollard
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 12, pp. 887-904
Open Access | Times Cited: 1579
Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 834
Harnessing innate immunity in cancer therapy
Olivier Demaria, Stéphanie Cornen, Marc Daëron, et al.
Nature (2019) Vol. 574, Iss. 7776, pp. 45-56
Closed Access | Times Cited: 751
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng, Wen Jiang, Betty Y.S. Kim, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 568-586
Open Access | Times Cited: 744
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin‐Acevedo, Bhagirathbhai Dholaria, Aixa Soyano, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 701
Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
Joseph Clara, Cecilia Monge, Yingzi Yang, et al.
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 4, pp. 204-232
Closed Access | Times Cited: 616
Advancing therapy for osteosarcoma
Jonathan Gill, Richard Görlick
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 10, pp. 609-624
Closed Access | Times Cited: 552
Cancer stem cell–immune cell crosstalk in tumour progression
Defne Bayık, Justin D. Lathia
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 526-536
Open Access | Times Cited: 379
T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan Trujillo, Randy F. Sweis, Riyue Bao, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 9, pp. 990-1000
Open Access | Times Cited: 342
Beyond immune checkpoint blockade: emerging immunological strategies
Shawn P. Kubli, Thorsten Berger, Daniel Vilarim Araújo, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 12, pp. 899-919
Closed Access | Times Cited: 339
A timeline of tumour-associated macrophage biology
Luca Cassetta, Jeffrey W. Pollard
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 238-257
Closed Access | Times Cited: 280
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Jennifer L. Guerriero
Trends in Molecular Medicine (2018) Vol. 24, Iss. 5, pp. 472-489
Open Access | Times Cited: 252
The Role of Macrophages in Cancer Development and Therapy
Ewa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1946-1946
Open Access | Times Cited: 249
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Emily Y. Yang, Khalid Shah
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 248
Targeting CD47 for cancer immunotherapy
Zhongxing Jiang, Haowei Sun, Jifeng Yu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 241
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Mark P. Chao, Chris H. Takimoto, Dong Dong Feng, et al.
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 221
Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
Chunxiao Li, Xiaofei Xu, Shuhua Wei, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001341-e001341
Open Access | Times Cited: 214
Macrophage targeting in cancer
Martha Lopez‐Yrigoyen, Luca Cassetta, Jeffrey W. Pollard
Annals of the New York Academy of Sciences (2020) Vol. 1499, Iss. 1, pp. 18-41
Open Access | Times Cited: 181
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Fatima Khan, Lizhi Pang, Madeline Dunterman, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 178
Cancer Stem Cells and Targeting Strategies
Luisa Barbato, Marco Bocchetti, Anna Di Biase, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 926-926
Open Access | Times Cited: 173
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
Yuchen Wang, Hao Zhang, Chao Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 172
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
Johanna Theruvath, Marie Ménard, Benjamin Smith, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 333-344
Open Access | Times Cited: 166
Intracavity generation of glioma stem cell–specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy
Chen Chen, Weiqiang Jing, Yu Chen, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 656
Closed Access | Times Cited: 165
CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages
Anujan Ramesh, Sahana Kumar, Dipika Nandi, et al.
Advanced Materials (2019) Vol. 31, Iss. 51
Closed Access | Times Cited: 163
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management
Guillermo Garcia‐Manero, Kelly S. Chien, Guillermo Montalban‐Bravo
American Journal of Hematology (2020) Vol. 95, Iss. 11, pp. 1399-1420
Open Access | Times Cited: 163
Page 1 - Next Page

Scroll to top